Understanding how tau protein is processed in Alzheimer's and related diseases
Project 1: Tau metabolism: molecular chaperones, targeting and proteolysis
This study is looking at how a protein called tau behaves in the brain, especially in conditions like Alzheimer's and frontotemporal dementia, to help us understand how it might be better managed or treated in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10891475 on NIH RePORTER |
What this research studies
This research investigates the metabolism of tau protein, which is crucial in neurodegenerative diseases like Alzheimer's and frontotemporal dementia. It aims to explore how tau interacts with molecular chaperones and how these interactions affect tau degradation. By examining both normal and mutated forms of tau, the study seeks to provide a comprehensive understanding of tau's role in disease progression. Patients may benefit from insights that could lead to new therapeutic strategies targeting tau metabolism.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or frontotemporal dementia, particularly those with known genetic mutations affecting tau metabolism.
Not a fit: Patients with tauopathies not related to Alzheimer's or frontotemporal dementia may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Alzheimer's disease and related tauopathies.
How similar studies have performed: Previous research has shown promising results in understanding tau metabolism, but this project aims to provide a more comprehensive approach that has not been fully explored.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kao, Aimee — University of California, San Francisco
- Study coordinator: Kao, Aimee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.